Endpoints News 生物医药· Lei Lei Wu·· 2026-10-05AI 评分29
Epicrispr 更新 EPI-321 治疗 FSHD 数据,继续显示令人鼓舞结果
Epicrispr builds case for FSHD treatment with updated data for EPI-321
AI 导读
Epicrispr 公布 EPI-321 治疗面肩肱型肌营养不良症(FSHD)的更新数据,继续显示令人鼓舞的试验结果。EPI-321 是一种表观遗传编辑疗法,针对这一遗传性肌肉疾病,更新数据涉及 12 人。
正文
Epicrispr Biotechnologies continued to show encouraging findings from testing of its epigenetic editing treatment for the genetic muscle disease facioscapulohumeral muscular dystrophy.
Twelve people have …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
来源:Endpoints News 生物医药 · endpoints.news